Skip to content

Staving off CTCL: How a Potential New Maintenance Therapy Could Benefit Patients

Richard Staines reports on new trial findings that could improve quality of life and lengthen survival times for patients with advanced disease.

Staving off CTCL: How a Potential New Maintenance Therapy Could Benefit Patients
Published: | 3 min read

Shutterstock

Cutaneous T-cell lymphoma (CTCL) is a rare type of cancer where the T-cells that normally help stave off infections become abnormal and begin to affect the skin. Richard Staines reports on new trial findings that could improve quality of life and lengthen survival times for patients with advanced disease.

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information